Babu Medi

Babu is an experienced pharmaceutical scientist with more than 16 years of biotech and pharmaceutical development experience across multiple modalities including monoclonal antibodies, recombinant protein vaccines, live virus vaccines, and cell therapies. He is well recognized in the drug product development area with several publications and patent applications. Babu is passionate and excited to be involved in developing cell & gene therapies to address unmet medical needs and to improve accessibility for patients.

Prior to joining Interius, Babu was Director of Formulation and Drug Product Development at Allogene Therapeutics, playing critical roles in multiple allogeneic CAR T cell therapy programs’ advancement from bench to clinic, tech transfer for drug product manufacturing, IND filings and pivotal process development, and process characterization for the lead program. Previously, Babu spent 10 years within the Vaccine Drug Product Development group at Merck & Co. leading formulation and drug product process development for multiple novel vaccine candidates including liquid, lyophilized and adjuvanted formulations. Babu led development teams, tech transfer, clinical drug product manufacturing campaigns for multiple products and modalities spanning early to late-stage development. Prior to Merck, he worked on novel formulations and delivery systems for vaccines and biologics at DelSite Biotechnologies.

Babu received his bachelor’s degree in Pharmacy from Andhra University, India and PhD in Pharmaceutical Sciences from North Dakota State University, Fargo, ND. He is a Registered Pharmacist in the states of Texas and Pennsylvania.